Related Experiment Video
Updated: Jul 11, 2026

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
Published on: August 19, 2014
A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint
Gabor Rohaly1, Jan Chemnitz, Silke Dehde
1Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie, Universität Hamburg, Martinistrasse 52, D-20251, Hamburg, Germany.
Abstract:
The archetypal human tumor suppressor p53 is considered to have unique transactivation properties. The assumption is based on the fact that additionally identified human p53 isoforms lack transcriptional activity. However, we provide evidence for the existence of an alternatively spliced p53 isoform (Deltap53) that exerts its transcriptional activity independent from p53. In contrast to p53, Deltap53 transactivates the endogenous p21 and 14-3-3sigma but not the mdm2, bax, and PIG3 promoter. Cell cycle studies showed that Deltap53 displays its differential transcriptional activity only in damaged S phase cells. Upon activation of the ATR-intra-S phase checkpoint, Deltap53, but not p53, transactivates the Cdk inhibitor p21. Induction of p21 results in downregulation of cyclin A-Cdk activity and accordingly attenuation of S phase progression. Data demonstrate that the Deltap53-p21-cyclin A-Cdk pathway is crucial to facilitate uncoupling of repair and replication events, indicating that Deltap53 is an essential element of the ATR-intra-S phase checkpoint.
Insights
A newly identified p53 isoform, Deltap53, shows transcriptional activity in damaged S phase cells. This tumor suppressor isoform activates the p21 gene, impacting cell cycle progression and DNA repair.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The tumor suppressor protein p53 is known for its transactivation properties.
- Existing human p53 isoforms are generally considered transcriptionally inactive.
- The role of p53 in DNA damage response is well-established.
Purpose of the Study:
- To investigate the transcriptional activity of a novel p53 isoform, Deltap53.
- To determine if Deltap53 possesses independent transactivation capabilities.
- To elucidate the role of Deltap53 in the intra-S phase checkpoint.
Main Methods:
- Analysis of alternative splicing in p53.
- Reporter assays to assess promoter transactivation by p53 and Deltap53.
- Cell cycle analysis in response to DNA damage.
- Western blotting to detect protein expression and activity.
Main Results:
- Deltap53, an alternatively spliced p53 isoform, exhibits transcriptional activity.
- Deltap53 selectively transactivates p21 and 14-3-3sigma promoters, unlike p53.
- Deltap53's activity is specific to damaged S phase cells and the ATR-intra-S phase checkpoint.
- Deltap53-induced p21 expression downregulates cyclin A-Cdk activity, attenuating S phase progression.
Conclusions:
- Deltap53 functions as a transcriptionally active tumor suppressor isoform.
- The Deltap53-p21-cyclin A-Cdk pathway is critical for uncoupling DNA repair and replication.
- Deltap53 is an essential component of the ATR-intra-S phase DNA damage checkpoint.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Non-LTR Retrotransposons
Abnormal Proliferation
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
DNA Damage Can Stall the Cell Cycle

